Human uroplakin lb gene structure and promoter analysis

Yu, 1994, Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins, J. Cell Biol., 125, 171, 10.1083/jcb.125.1.171

Finch, 1997, Chromosomal localization of the human urothelial “tetraspan” gene, UPK1B, to 3q13.3–q21 and detection of a TaqI polymorphism, Genomics, 40, 501, 10.1006/geno.1996.4589

Lobban, 1998, Uroplakin gene expression by normal and neoplastic human urothelium, Am. J. Pathol., 153, 1957, 10.1016/S0002-9440(10)65709-4

Wu, 1993, Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein, J. Cell Sci., 106, 31, 10.1242/jcs.106.1.31

Lin, 1994, Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane, J. Biol. Chem., 269, 1775, 10.1016/S0021-9258(17)42095-3

Lin, 1995, A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 92, 679, 10.1073/pnas.92.3.679

Kallin, 1991, Cloning of a growth arrest-specific and transforming growth factor beta-regulated gene, TI 1, from an epithelial cell line, Mol. Cell. Biol., 11, 5338, 10.1128/MCB.11.10.5338

Adachi, 2000, Human uroplakin Ib in ocular surface epithelium, Invest. Ophthalmol. Visual Sci., 41, 2900

Olsburgh, 2002, Uroplakin gene expression in normal human tissues and locally advanced bladder cancer, J. Pathol.

Harrington, 2000, Transcriptional control: an essential component of cancer gene therapy strategies?, Adv. Drug Delivery Rev., 44, 167, 10.1016/S0169-409X(00)00093-4

Southgate, 1995, Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines, Br. J. Cancer, 72, 1214, 10.1038/bjc.1995.488

Southgate, 1994, Normal human urothelial cells in vitro: proliferation and induction of stratification, Lab. Invest., 71, 583

Ioannou, 1994, A new bacteriophage P1-derived vector for the propagation of large human DNA fragments, Nat. Genet., 6, 84, 10.1038/ng0194-84

Schmidt, 1999, CapSelect: a highly sensitive method for 5′ CAP-dependent enrichment of full-length cDNA in PCR-mediated analysis of mRNAs, Nucleic Acids Res., 27, e31, 10.1093/nar/27.21.e31

Mount, 2000, Genomic sequence, splicing, and gene annotation, Am. J. Hum. Genet., 67, 788, 10.1086/303098

Lo, 1996, Generality of a functional initiator consensus sequence, Gene, 182, 13, 10.1016/S0378-1119(96)00438-6

Andria, 1991, Genomic organization and chromosomal localization of the TAPA-1 gene, J. Immunol., 147, 1030, 10.4049/jimmunol.147.3.1030

Hotta, 1992, Genomic structure of the ME491/CD63 antigen gene and functional analysis of the 5′-flanking regulatory sequences, Biochem. Biophys. Res. Commun., 185, 436, 10.1016/S0006-291X(05)81004-6

Rubinstein, 1993, Organization of the human CD9 gene, Genomics, 16, 132, 10.1006/geno.1993.1150

Korinek, 1993, Genomic structure of the human CD53 gene, Immunogenetics, 38, 272, 10.1007/BF00188803

Finch, 1999, Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue, Int. J. Cancer, 80, 533, 10.1002/(SICI)1097-0215(19990209)80:4<533::AID-IJC9>3.0.CO;2-5

Kerr, 1990, TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence, Cell, 61, 267, 10.1016/0092-8674(90)90807-Q

Booth, 1997, Stromal and vascular invasion in an human in vitro bladder cancer model, Lab. Invest., 76, 843

Scriven, 1997, Reconstitution of human urothelium from monolayer cultures, J. Urol., 158, 1147, 10.1016/S0022-5347(01)64407-0